PFS and Injectable Drug Devices East Coast

Memo

The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including: Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00 Venue details: Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, 02199, United States Category: Conferences | Science, Health and Medicine | Pharmaceuticals Price:General Admission: USD 3197.00 Speakers: Mark Howansky VP, Device Development and Commercialization, Viridian Therapeutics, Theresa Scheuble Director R and D Drug Delivery Systems, Johnson and Johnson, Amin Sedighiamiri Senior Director, Device Development and Technology, Merck, Monica Swinney Sr. Director and Head, Drug Delivery Innovation and New Product Planning, Gilead Sciences, Sujit Basu Vice President and Head, Pharmaceutical Development, Ionis Pharmaceuticals, Mark DeStefano Global Technology Innovation, Combination Products and Device Research and Development, Teva Pharmaceuticals